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Abstract
The US Brain Research through Advancing Innovative Neurotechnologies Grand Challenge and
the EU Human Brain Project Future and Emerging Technologies Flagship, though seemingly simi-
lar in many dimensions, have distinct features that have been shaped by politics and institutional
systems. This article documents the history of the two projects and compares their organization
and funding mechanisms. While there is a call for Grand Challenges to motivate science, organiza-
tional factors and the mechanisms for allocating funding will have a great influence on the ultimate
project outcomes. These two divergent examples suggest alternative strategies to consider when
organizing future Grand Challenges, and provide context that should be considered when evaluat-
ing the outcomes of large public investments in science.
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1. Introduction
The European Union (EU) and the USA are simultaneously engaged
in Grand Challenge research initiatives dedicated to mapping the
human brain. The term Grand Challenge has captured the public im-
agination as a means to motivated large-scale scientific progress.
The term gained popularity in 2003 when the Bill & Melinda Gates
Foundation identified fourteen Grand Challenges in global health
(Singer et al. 2011).1 It is widely referenced that the concept origi-
nated in 1900 with David Hilbert’s articulation of twenty-three im-
portant mathematical problems that set the agenda for
mathematical research in the twentieth century (Omenn 2006:
1696; Grand Challenges Canada 2011: iv; JIIP 2012: 12; Gates
2013: A16). The discourse of Grand Challenges is now well estab-
lished in policy making.2
Scientific research is a continually-ongoing endeavor. Grand
Challenges—also sometimes referred to as ‘global’, especially by the
The Organisation for Economic Co-operation and Development
(OECD) or the UK Royal Society, or ‘societal’ (Kallerud et al 2013:
7)—articulate ambitious goals to harness scientific resources to solve
important problems. In this case, the objective is to better under-
stand and treat diseases ranging from autism to schizophrenia by
mapping the human brain. The European Commission’s (EC)
Human Brain Project (HBP) was announced in January 2013. The
US project, with the acronym, Brain Research through Advancing
Innovative Neurotechnologies (BRAIN), was announced in April
2013. Both Grand Challenge projects are characterized as ‘visionary’
and aim to be transformative with purpose-driven research that is
both multidisciplinary and collaborative, relying on the integration
of information technology and neuroscience. Both Grand Challenges
support basic research; however, generating new technologies and
(eventually) increasing competitive economic advantage are promin-
ently mentioned as intended outcomes. These characteristics distin-
guish them from mission-oriented R&D projects—such as Apollo or
the Manhattan Project—and represent new challenges for science
(Foray et al. 2012: 1698). Moreover, despite having a similar re-
search focus, the two Grand Challenges differ in significant ways, re-
flecting institutional context and political negotiations.
The two Brain Grand Challenge initiatives may be viewed as ex-
periments in the organization and allocation of resources for ambi-
tious, high-risk scientific projects. The two projects offer contrasting
organization—with the EU project highly centralized, while the US
project is highly decentralized. For far too long the emphasis has
been on the scale of funding. While, of course, more money is al-
ways preferred to less, it is the organizational design factors that de-
termine how money is allocated, and to whom. Thus, the design of
the Grand Challenge project—which includes the determination of
eligible participants, the incentives, and the parameters that influ-
ence the pace of progress—may be even more important than the
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scale of funding. The institutional origins of science policy initiatives
are, inter alia, of utmost importance in evaluating their success
(Link 2014). We argue that, in addition, the design and implementa-
tion of the Grand Challenges will determine their ability to ultim-
ately achieve their objectives.
Our purpose is to document and highlight the above mentioned
differences between these two projects for any future evaluations,
and to offer insights that may be useful to the design of future
Grand Challenges. The next section discusses the history of the evo-
lution of the idea of mapping the human brain. While the idea of
understanding the human brain has been aspirational for a very long
time, recent technological advances have helped bring us within
reach of achieving this objective. Although the development and
adoption of new, more effective, technologies is a necessary condi-
tion, it is not a sufficient one for achieving the aims of Grand
Challenges (Foray et al. 2012: 1697). Following this, we consider
how each of the two initiatives entered public discourse and received
the Grand Challenge designation. We then describe and delineate
the institutional frameworks of both the HBP and the BRAIN. This
provides us with the opportunity to draw comparisons of these two
Brain Grand Challenge initiatives in terms of: their embeddedness in
institutional setups, the participating entities, organization of the
projects, budgetary constraints, and project criticisms. Familiarity
with different, already existing, Grand Challenges can provide use-
ful insights not only for their evaluation, but also to offer guidance
for the development of new Grand Challenge initiatives. The article
ends with contemplation on possible future evaluation challenges.
2. Evolution of the idea of mapping the
human brain
Schizophrenia, depression, epilepsy, dementia, alcohol dependence
and other mental, neurological, and substance use (MNS) disorders
constitute 13 per cent of the global burden of disease, surpassing
both cardiovascular disease and cancer (Collins et al. 2011). Table 1
provides disability-adjusted life years (DALY3) for specific MNS dis-
orders. These disorders also constitute a major financial burden;
yearly costs of brain diseases are estimated at e800 billion in the EU
(DiLuca and Olesen 2014). In the USA, the cost of caring for people
with Alzheimer’s disease alone is over $200 billion per year
(Strategy for American Innovation 2015). Across all countries, in-
vestment in fundamental research into disorders affecting the brain
is disproportionately low relative to the disease burden (Saxena
et al. 2007).
Scientific understanding of the brain has proven elusive, despite
significant advances in the understanding and treatment of diseases
affecting other organ systems. The idea of mapping the human brain
has a long history dating at least as far back as the seventeenth
century (Zimmer 2004; Wade 2010). Starting in the mid-nineteenth
century it became scientifically fashionable to map the functions of
the brain using a variety of methods and techniques. Advances in
neuroscience—a relatively young scientific field that emerged in the
mid-twentieth century—have generated a scientific basis to begin
achieving an understanding of the brain’s structure and functions
(Pechura and Martin 1991). Neuroscience is an emerging scholarly
field that is concerned with the scientific study of the brain and cen-
tral nervous system (Finger 1994 provides a historical account of the
development of the field.). It has been a splintered field with a variety
of different approaches and orientations seeking to dominate the field
(Koch and Reid 2012: 397). Advances in less invasive imaging
technologies—such as functional magnetic resonance imaging—have
helped provide a greater understanding of neurons, circuits, and
brain systems (Kandel and Squire 2000).
US President Bush declared the 1990s as the Decade of the
Brain. This declaration was not accompanied by a significant fund-
ing commitment to brain science, however, the simple act of a
Presidential Declaration was beneficial as it brought visibility to the
field of neuroscience (Jones and Mendell 1999). Interest in the brain
also caught public attention with actions such as the month of May
being proclaimed by the EC as ‘European Month of the Brain’, or
the Brain Awareness Week (supported by the Society for
Neuroscience), which has attracted support from thousands of or-
ganizations across the globe (Castillo 2015). The idea for the latter
originally started in 1993 by the Dana Alliance for Brain
Initiatives—an initiative of the Dana Foundation, a private philan-
thropic organization established in 1950 and dedicated to advancing
brain research. In 1994, a document titled Grand Challenges in
Medical Informatics by Dean F. Sittig, an expert in Biomedical
Informatics, included the objective of ‘a complete three-
dimensional, digital representation of the body, including the brain’.
Sitting’s ideas, which were highly cited in other relevant documents
and publications, helped popularize the concept of brain mapping.
Inspired by the success of the Human Genome Project (HGP),
the parallel idea of mapping the human brain began gaining scien-
tific and political traction in the early 2000s (Fitzpatrick 2016). The
parallels in using the term ‘mapping’ in the naming of the projects is
obvious, as is the idea of understanding these fundamental struc-
tures. Along with these parallels, however, there are some important
distinctions. The HGP was an international, collaborative research
project formally launched in 1990 with the objective of a complete
mapping of all the genes of human beings (Cook Deegan 1994). A
similar and competing project was conducted outside of government
by the Celera Genomics. The latter was formally launched in 1998,
creating a scientific race (Shreeve 2004) with the Human Genome
that was declared complete in 2003.
Horgan (2013) warns for caution in comparisons of the Brain
Mapping Grand Challenges to the HGP. Horgan (2013) points out
Table 1. Global burden of MNS disorders, DALYsa (millions)
Rank Cause DALYs (in millions)
1 Unipolar depressive disorders 65.5
2 Alcohol use disorders 23.7
3 Schizophrenia 16.8
4 Bipolar affective disorder 14.4
5 Alzheimer’s and other dementias 11.2
6 Drug use disorders 8.4
7 Epilepsy 7.9
8 Migraine 7.8
9 Panic disorder 7
10 Obsessive-compulsive disorder 5.1
11 Insomnia (primary) 3.6
12 Post-traumatic stress disorder 3.5
13 Parkinson’s disease 1.7
14 Multiple sclerosis 1.5
Data from WHO (2008). Examples of MNS disorders under the purview
of the Grand Challenges in Global Mental Health initiative.
aA DALY is a unit for measuring the amount of health lost because of a dis-
ease or injury. It is calculated as the present value of the future years of dis-
ability-free life that is lost as a result of the premature deaths or disability
occurring in a particular year.
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that the Genome Project was built upon a basic understanding of gen-
etics that dated back decades to when researchers first deciphered the
genetic code and defined sets of rules whereby specific sequences of
base pairs in DNA generate specific proteins. Progress in neuroscience
has been more fragmented. The prevailing understanding is that the
brain operates according to a neural code. This notion relies on func-
tional scans of activities in brain regions, and smaller scale expression
of neurotransmitters and their receptors in individual neurons. The
connection between these two scales is conceptualized as a map of the
human neural network, or human brain that draws heavily on the in-
tegration of computer and information science.
Philanthropic foundations played a catalyzing role in defining
the field of brain mapping. A culminating event was the 2011 Allen/
Gatsby/Kavli Workshop that produced a proposal for a large-scale
public initiative, called the Brain Activity Map (BAM) project
(Alivisatos et al. 2012). When this initiative was formally
announced, many public and private organizations were already
championing or funding projects in the field. Philanthropist Paul
Allen started an initiative with the goals of understanding how the
human brain works, and changing the way that researchers ap-
proach brain disease and disorder in 2000. In 2003, the Allen
Institute for Brain Science began mapping regions of gene activity in
the mouse brain and pooling results into online databases, or atlases
(Koch and Reid 2012). The open provision of comprehensive maps
of brain activity facilitated further research. The UK Gatsby
Charitable Foundation, funded in 1967 by David Sainsbury, began
investing in neuroscience in 1990. Their goal, ‘Supporting world-
class theoretical and experimental research on neural circuits and
behaviour, and activities’, aligns with the current direction in the
field. The Kavli Foundation (2000) has championed the Brain pro-
ject through organizing symposia, as well as bringing together differ-
ent researchers at their Kavli Institute, which have published papers
on the brain mapping initiative. The 2012 drafted paper in Neuron
has authors who are mostly (all but two) connected to the Kavli
Foundation (the most visible author, George Church, being one of
the people who helped initiate the HGP initiative). The relative
speed of the process itself can thus be attributed to an already exist-
ent cohort of combined efforts in this area.
On the eve of the Grand Challenge announcements, a 2014
Elsevier report, Brain Science: Mapping the Landscape of Brain and
Neuroscience Research, found that 1.79 million brain and neurosci-
ence research articles were published between 2009 and 2013. This
represented one-sixth of the world’s total publication output
(Elsevier 2014: 3). Still, Holzinger (2014: 35) claims that although
much progress has been made, many of the points articulated in
Sittig’s 1994 goals are still unrealized after 20 years.
3. Getting on the public agenda
Grand Challenges require that heterogeneous elements and forces
have to be mobilized, guided, and integrated; taking into account
that perspectives on the problem at hand, and what constitutes its
resolution, can differ significantly across various groups (Kuhlmann
and Rip 2014). The process of defining the objectives of the Grand
Challenge, garnering support from various constituencies, and
reaching consensus, is achieved through agenda setting. While indi-
viduals or private foundations engage in an internal process, the
public definition of a Grand Challenge is more transparent and
based on this initial agenda-setting process. The two Grand
Challenges differ significantly in the ways they emerged on their
respective political agendas (Fig. 1), although both ultimately led to
what could be called initiatives driven by institutional pillars of sci-
ence policy—actors who are consummate insiders and agenda set-
ters (Hicks 2016).
In Europe, several groups have produced influential documents;
some aimed at defining and formulating the Grand Challenge ap-
proach and others working to point toward specific Grand
Challenges. The 2008 report Challenging European Research:
Rationales for the European Research Area, by the ERA Expert
Group, emphasized the need to engage the European research sys-
tem in Grand Challenges and the need for corresponding invest-
ments. In 2009, the so-called Lund Declaration emphasized that
Europe must focus on the Grand Challenges of our time by connect-
ing science organizations, politicians, and industry representatives.
Both reports could be seen as key EU documents furthering the
Grand Challenge discourse in Europe (see also Wissenshaftsrat
2015: 9, 10). Other important documents include: The Role of
Community Research Policy in the Knowledge-based Economy
(2009); Strengthening the Role of European Technology Platforms
in Addressing Europe’s Grand Societal Challenges (2009), ICT-FP7
Work Programme 2011-2012 (2011).
In regard to establishing brain research as one of the fields inside
the Grand Challenges approach some documents also need to be
pointed out. Two Information and Communications Technology
(ICT) Advisory Board’s (ISTAG) reports from 2009 (a year prior to
the initial call for EU Grand Challenge Flagship Pilots) are of par-
ticular interest: ISTAG Recommendations on Future and Emerging
Technologies and ISTAG Report on European Challenges and
Flagships 2020 and beyond. The first report identifies the recording
and imaging of the brain as one of the long-term challenges in ICT
(ISTAG 2009a: 32). The second report sees ‘a breakthrough . . .
“Understanding life . . . no longer science fiction but . . . becoming a
feasible challenge thanks to the advances in biological sciences and
in ICT” (ISTAG 2009b: 17) and list as possible directions of the re-
search inter alia in Simulating Life Challenge, Emulating Life
Challenge, and Neuro-ICT Challenge (ISTAG 2009b: 18, 19).
Interestingly, Henry Markram, who later became head of the HBP,
was a member of the ISTAG at the time these reports were pub-
lished. Furthermore, in the Joint Institute for Innovation Policy’s
Study to Assist the European Research Area Board: Investing in
Research and Innovation for Grand Challenges (2012) healthy age-
ing appears among two listed examples of Grand Challenges in the
last document, where various ICT-related research and imaging are
discussed (JIIP 2012: 24). Furthermore, human brain research was
already present in the EU’s 2010 Future and Emerging Technologies
(FET) Flagship call for proposals, and in the European Forward
Looking Activities Report that emphasized the need for ‘better
knowledge of human brain’ (European Commission 2011: 5).
Hence, the EU’s scientific and political rhetoric of Grand
Challenges is well established, and is also apparently here to stay:
the EU has in May 2016 announced the new Quantum Technologies
Grand Challenge; launching another e1 billion worth flagship. The
study of the brain has also already gained its place inside the Grand
Challenges and was crystallized as such through various official
channels, previous funding schemes, and competitions. In the EU,
more than e2 billion were dedicated to brain research starting in
2007; additionally, brain science has become a part of the main-
stream EU research agenda (DiLuca and Olesen 2014: 1208). Brain
research and combating major diseases related to brain health was
one of the European major fields of community action within the
Seventh Framework Programme for Research and Technological
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Development (FP7)—EU’s main instrument for funding research be-
tween 2007 and 2013. With that said, combating major brain dis-
eases was not included in the FP7 until the very last moment,
following pressure generated by newly-published brain science re-
search results (Olesen et al. 2006; Sobocki et al. 2006). However,
the research area had never achieved such (political and research)
traction as it has today through this single project.
The HBP was conceived at the interface of neuroscience and in-
formation technology, similar to its direct predecessor, the Blue
Brain Project, which had the same leading institution, and partners.4
Henry Markram is strongly identified with the HBP, providing an
example of science policy advocacy (Dickson 1988). We concur that
maneuvering by the scientific community is a surprise only to those
who believe the scientists’ plea is above politics (Dickson 1988). It is
often claimed that HBP was sold by the charismatic Henry
Markram with his politically-expedient rhetoric.
The selection of the HBP—as a so-called FET Flagship—was a
formal, multiyear, top-down multistep procedure, with (anonym-
ous) peer-to-peer reviews. This formal selection process should in-
crease transparency, decrease subjectivity, and in abstractu increase
the autonomy of the scientific community. However, while scientists
usually do a good job in evaluating scientific merit, they tend to
have more problems in evaluating the utility of the projects.
Opponents have also criticized the selection process as secretive; al-
though the European Commission (2014: 24) insists that the selec-
tion process was competitive and driven by scientific excellence.
Interestingly, the other selected FET Flagship—the Graphene
Project—was never submitted to such detailed scrutiny.
Nonetheless, the fact remains that the peer-to-peer selection proc-
esses are seen as increasingly problematic (Irvine and Martin 1985)
in a world where Grand Challenge projects demand increasing fund-
ing and where there is a high concentration of research activity in-
side individual big research consortia.
President Obama’s State of the Union address in February 2013,
days after the EU announced the HBP, mentioned the new BRAIN
project as built upon the 2011 BAM (Insel et al. 2013; Yuste and
Church 2014). The designation of BRAIN Grand Challenge relied
on the President’s initiative, with the support of the Office of
Science and Technology Policy (OSTP). OSTP was uplifted by the
fact that plenty of efforts already existed in this field. Another dis-
tinctive feature of BRAIN is its reliance on informal interactions, as
has often been the case in the past (Brooks 1978; Cook Deegan
1994). The descriptions of formal decision-making processes can
only be seen as an approximation, due to the importance of informal
interactions (Brooks 1978; Dickson 1988).
Hicks (2016) traces the emergence of the Grand Challenges in
the US science policy to Kenneth G. Wilson, who emphasized the
importance of leveraging supercomputers (in basic science)—an
issue strongly ingrained in the current brain initiatives—back in the
1980s. This made high performance computing the field in which
the idea of Grand Challenges first permeated science policy—as evi-
denced by the High Performance Computing and Communication
program in the 1980s, and the regulatory framework with the High
Performance Computing Act of 1991 (Hicks 2016).
The first mention of the Grand Challenge from a federal agency
in the field of brain research was in the Report on Grand Challenges
of Mind and Brain—drafted after workshops were held at the
National Science Foundation (NSF) in 2006—that described emerg-
ing issues and new directions for research in neuroscience and cogni-
tion. Several elements were seen as critical to the success of the
initiative, including multidisciplinarity and the importance of broad
questions that could be solved by many small-scale partnerships ra-
ther than by few large-scale clusters. Some other documents on
Grand Challenges that are loosely connected to the brain research
field include: Grand Challenges for Biological and Environmental
Research: A Long Term Vision from the Department of Energy
(DOE) (2010) and Grand Challenges: Science, Engineering, and
Societal Advances Requiring Networking and Information
Technology Research and Development (2006) by the Interagency
Working Group on Information Technology Research and
Technology; and A New Biology for the 21st Century of the
National Research Council (2009)—the latter also points out that
society at large could benefit from large-scale efforts to understand
how the brain works. Brain research, or even the more general topic
of neuroscience, was not listed among examples of possible Grand
Challenges by the President; neither in the original President’s
Strategy for American Innovation from November 2009, nor in the
revised Strategy from 2011. However, brain research has been
prominently mentioned in the Strategy revision of 2015.5
Furthermore, there is evidence that an informal advocacy process
operated, with bipartisan congressional support and active biparti-
san congressional actors, for example, the bipartisan Congressional
Neuroscience Caucus that was established in 2010. The purpose of
the Caucus is threefold: to build awareness of brain research, to help
communicate the progress and benefits of brain research, and to in-
form policy makers. A particularly strong advocate was also
Congressman Chaka Fattah, who launched his Fattah Neuroscience
Initiative back in 2011. Neuroscience continued to gain momentum
within federal agencies, as evidenced by the many government re-
ports written on the various scientific challenges in the field. Though
momentum started building in the 2000s, brain science gained even
more political traction in the USA sometime after 2011. Around this
time, with the increased activity around brain science research, there
was encouragement from Congress to consolidate neuroscience pro-
jects. Thus, the Interagency Working Group on Neuroscience
(IWGN) was established in 2012 (and re-established in 2015 after
releasing its final report in 2014), with participation from over
twenty agencies and departments, including the NSF, the DOE, etc.
The IWGN is part of the wider White House Neuroscience Initiative
that promotes partnerships with the private sector to advance neuro-
science research.
4. Grand challenge institutional frameworks
Grand Challenges rely on institutional frameworks as they work to
solve scientific problems. Their institutional frameworks enable
them to determine: who participates, how resources are allocated,
and how the inevitable disputes should be addressed and resolved.
These institutional frameworks provide the rules, or guidelines, that
projects must adhere to during the Challenge.
Both Grand Challenges declare the potential commercial value
of research results and emphasize their potential to create new
industries and jobs for the future. While the Grand Challenges ac-
knowledge their potential to impact economic development, they
are both—first and foremost—science projects. There has long been
emphasis on ‘some sort of direct transfer from science as a mode of
knowledge to technology as a mode of know-how for making useful
things and performing useful activities’ (de Sola Price 1984); this
would be a strong argument for inclusion of more companies from
early on to expedite this possible trickle-down effect of Grand
Challenge initiatives. However, as we will see, the current approach
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of both projects has been somewhat different in terms of inclusion
stakeholders. There is, however, a joint vision in the EU and in the
USA that—following technology development—both brain initia-
tives should offer an infrastructure for sharing relevant tools.6
EU research programs are required to satisfy legal and political
obligations dictated by the Amsterdam Treaty and resource alloca-
tion decisions made by the EU follow a prescribed selection process.
However, the EU is not necessarily the most logical administrative
decision-making unit because of distinct national research policies in
addition to limited supranational integration.
As a designated part of EU FET Flagship initiative (Fig. 2), the
HBP’s main objective is to simulate the functioning of the human
brain with a supercomputer. This objective re-enforces the idea that
this Grand Challenge is an ICT initiative.
The EU is committing e1 billion in the next 10 years to this sin-
gle and centralized project. Half of that amount was provided by the
EC, and the other half mainly by Member States. FLAG-ERA, the
Flagship European Research Area Network, was established in 2013
to gather national and regional funding to support the flagships (as
well as nonselected flagship pilots7) inside the so-called partnering
part, providing further funding opportunities for other interested
(research or business) partners. However, funding organizations
from only eleven countries (out of twenty-eight EU Member States,
plus Turkey) were participating in the 2015 Joint Transnational Call
(JTC) that supported the HBP; furthermore, only ten countries par-
ticipated in the 2016 JTC, supporting the four nonselected FET
Flagship Pilots.8 Most notably absent from both calls was Germany.
Hence, this vertical splitting of funding with expected major contri-
butions by the EU Member States is cause for concern, especially
given that only a few of them have made serious commitments (the
same can be said for planned private contributions). The initial
funding for HBP comes from the FP7 schemes. It was not until the
signature of the Framework Partnership Agreement in October
2015, while the project was entering the end of the FET Flagship’s
‘Ramp-Up Phase’, that HBP was officially financially made part of
the FET Flagship. However, this initial funding, related to FP7, does
not increase the flexibility of the funding, since the budgetary frame-
work was pre-planned.
Coordination of the HBP is centralized with the leading partner
Ecole Polytechnique Fe´de´rale de Lausanne (EPFL) based in
Switzerland. Barriers in achieving European leadership in this area
are seen in fragmentation and under-investment, which could ex-
plain why the project was designed to be centralized and receptive
of a large influx of funding. Another interesting political note is that
the EU is willing to fund a major project that is coordinated by an
organization that has its headquarters outside the EU borders.
However, all organizations based in the European Economic Area
are eligible to receive funding from EU, due to the Agreement on the
European economic area.
HBP emphasizes scientific excellence in terms of involved actors,
with only three companies listed among partners. In general terms,
the flagships aim to deliver world-beating science at the crossroads
of science and technology (European Commission 2013). In a way,
this is contradictory to the ideas emerging inside the EU and empha-
sized inside Horizon 2020, whereby a more utilitarian view of sci-
ence has been adapted. Hence, the project seems to be set up to
contribute to the European paradox in the field of brain science; the
EU scientific performance being ‘excellent’ compared to its biggest
competitors (e.g. the USA), while Europe’s major weakness lies in
the difficulty of transforming the results of the research into innov-
ations and, ultimately, competitive advantages. However, some
argue it is not only the formal institutional framework that provides
a barrier, but also the lack of European companies that would be
able to step in to those sectors with the greatest opportunities for
innovation-based growth (Veugelers and Cincera 2015). The OECD
data on the revealed technological advantage (RTA), based on pa-
tent data, seems to indicate a similar story; demonstrating that there
does not seem to be any technological advantage in the biotechnol-
ogy field in Europe (although some individual countries differ from
this general picture), whereas the USA does appear to have a techno-
logical advantage in this field (OECD 2015: 196). This deficiency
allows multinational and US firms to benefit from major European
advances (Dosi et al. 2005: 32). Also the process of defining the
Grand Challenges is itself mostly confined to so-called scientific
elites; although a strong emphasis is in abstractu on uniting ‘all rele-
vant forces across Europe in working towards solutions for soci-
etal challenges’ (e.g. Strengthening the Role of European
Technology Platforms in Addressing Europe’s Grand Societal
Challenges 2009: 8).
HBP has often been criticized; this culminated in the Open Letter
(2014) signed initially by more than 100 individuals (who were eli-
gible for HBP funding) and an evaluation–formally, a mediation
process–in 2015. The project was criticized inter alia for lack of
transparent administration, with the evaluation highlighting the
need for a more efficient organizational structure. In a situation
where projections showed more funding would be required, a high
degree of administrative centralization presents a possible barrier to
realizing scientific progress.
The US approach, called an ‘all hands on deck’ approach by
President Obama, is decentralized, involving multiple federal mis-
sion agencies, private philanthropic foundations, and for-profit
firms (Fig. 3). Among industrial partners, the US Photonic Industry,
GlaxoSmithKline, Google, General Electric, and some others are
mentioned inside the BRAIN Grand Challenge. However, this ap-
proach does not only encompass the implementation level of indi-
vidual Grand Challenges, but also their conceptual level; some firms
have defined additional Grand Challenges that have the potential
for wide societal benefits (e.g. SpaceX’s ‘making humanity a multi-
planetary species’, or Google’s self-driving cars); see also Strategy
for American Innovation 2015. The BRAIN Grand Challenge is
accompanied by three other so-called Presidents 21st Century
Grand Challenges, which are implemented by different government
agencies that have identified ‘North Stars’ in US research endeavors
(e.g. NASA implementing the Asteroid Grand Challenge). Despite
these additional Grand Challenges, the BRAIN appears to be the
‘poster-child’ for them, partially because it has garnered the most di-
verse agency support.
The number of federal agencies participating in the BRAIN initia-
tive is continuously increasing. Currently involved are: the National
Institutes of Health (NIH), the Defense Advanced Research Projects
Agency (DARPA), the NSF, the Intelligence Advanced Research
Projects Activity (IARPA), the Food and Drug Administration (FDA),
and—the latest participant—the DOE. This range of participating
federal agencies provides diversity to the developing research port-
folio, but also presents coordination challenges, with the possibility to
‘devolve into a wish list’ (Yuste and Church 2014).
The criticism of the BRAIN thus far has been much more
reserved than the criticism of the HBP. Most criticism is confined to
individual criticisms (see e.g. Fields 2013; Horgan 2013), often
related also to the fact the BRAIN is more a bundle of projects in the
same field, rather than a single Grand Challenge project. The
Advisory Committee of the Brain Working Group’s (NIH ACD)
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document BRAIN 2025 provides a vision for this project. The docu-
ment identifies seven goals, which appear to be in line with the pre-
vious plan ‘to significantly extend and shape the vision’ of the BAM
(Insel et al. 2013). Although the document provides a scientific
plan—including timetables, milestones, and cost estimates—for
achieving project goals, different involved agencies strive to achieve
different individual goals and the abovementioned document pri-
marily represents the perspective of the NIH. Hence, this decentral-
ization of efforts may present future problems when evaluating the
overall results of the BRAIN.
The BRAIN project was seeded with approximately $100 million
from public funds, with private partners committing more than
$100 million annually.9 The project has two distinct features: a hori-
zontal decentralization of funding organizations and financial com-
mitments from both the public and private sectors. The President’s
budget increased federal funding to more than $300 million in
2016; and, in March 2016, the commitment for financial year 2017
has more than quadrupled from the initial $100 million per year
(The White House 2016). General funding trends also play a role.
The US Congress tends to increase funding for biomedical research;
hence, the White House requested lower funding while anticipating,
and relying on, this increase (Dickson 1988). The BRAIN is an ex-
cellent example of this; NIH will get $25 million more than re-
quested in 2016 in order to support this challenge. Many different
ideas exist on how NIH funds should be allocated (Sampat 2012).
The BRAIN challenge follows a viewpoint, identified with many
prominent researchers, that NIH should fund research that is, in its
nature, basic research. However, the designation of a Grand
Challenge implies that a more practical output is expected, shifting
the image and discourse of the research to be done toward health in-
stead of science, since it was argued that this is what gets a lot more
traction with the Congress and the public (Kaiser et al. 2010). Year
to year budgeting provides elasticity, and increasing funds are bound
to have positive effects.
5. Conclusions
Calls for accountability in the use of public funds require greater at-
tention to institutional context and organizational structure, as these
ultimately determine the evaluation of a project’s success. As it was
pointed out by Flyvberg et al. (2003: 73), projects do not exist in the
simple ‘Newtonian world of cause and effect, but rather in a reality
where the implementation is highly stochastic’. Thus, Grand
Challenge projects—often riddled with fundamental uncertainties—
rarely end up as originally planned in terms of involved actors,
budgetary commitments, and results. Any subsequent evaluation ef-
forts face not only a complicated societal reality—with a plethora of
desired objectives for the Grand Challenge projects—but also must
overcome the fact that Grand Challenge projects are complex on their
own. There are several factors that contribute to the challenging task
of evaluation. Science and technology interact with society in a com-
plex way, as their effects are often neither immediate nor direct, but
often occur indirectly and after a substantial time delay. There is un-
certainty about tomorrow’s developments, including the fast pace of
(sometimes) competing technological changes and solutions. Grand
Figure 1. Important documents defining the Grand Challenge approach and the role of brain research therein, for EU and the USA from 2006 to 2013.
Notes: We agree with Kallerud et al. (2013: 4) that ‘as the number and variety of uses and developments of the Grand Challenges rapidly increases, it becomes im-
possible to make an exhaustive map of these developments’. Hence, the need to make choices about which documents to highlight as important or exemplary is
inevitable. Please keep in mind also that our narrower focus to Brain Grand Challenges dictated the authors’ selection.
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Challenge projects often rely on the populist rhetoric of the projects,
where the real potential—and, subsequently, the goal—is sometimes
less clear, making comparisons with the base-line difficult. This
goes hand in hand with difficult evidence gathering (Levidow
and Papaioannou 2016) in light of the fact that the ultimate out-
put (national health) is a quintessentially public good (see mutatis mu-
tandis for defense-related projects in Mowery 2012: 1709).
Increased budgetary demands of the projects are accompanied
with lock-in effects, where existing projects call for either
increased funding or, at least, a steady income of funds—based on
the idea that a significant amount of funding has already been
locked into a certain endeavor. There is also a plethora of involved
actors, and their interactions are sometimes difficult to assess.
The evaluation will hence need to combine: diagnoses of the (pre-
sumed and current) problem(s); the analysis of (non)impacted soci-
etal visions; interposing policy narratives; objective cost-benefit
analysis (including spin-outs positive effects); and diligent evidence
gathering.
Figure 2. EU HBP science policy landscape.
Figure 3. US BRAIN science policy landscape.
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In order to effectively capture the effects of both initiatives, mul-
tiple evaluation methods will need to be considered. The authors sug-
gest inter alia to employ a burst data mining-based technique called
DETECTS, originally developed by Kleinberg (2003) and recently
applied to patent and publication data by Dernis et al. (2015). Patent-
and publication-based bursting allows detecting the emergence of
technologies as well as the evolution and co-development trajectories
that occur in science (and technology). A patent-based bursting evalu-
ation would show if relevant patent (International Patent
Classification) fields connected to brain mapping inside published pa-
tent documents show any significant signs of bursting; that is, whether
there is significant increase in those applications. This indicates not
only new emerging technologies in the field (spin-off effects), but also
whether the brain initiatives have truly generated the promised ‘excite-
ment’ inside the research community, both in the academia and the
industry.
As demonstrated above, we were able to identify several differ-
ences between the projects. Some— including Sean Hill, the
co-director of the HBP’s neuroinformatics team, and Rafael Yuste,
one of the authors of the BAM paper—believe the US and EU initia-
tives have complementary missions. The BRAIN aims to create tools
for imaging and controlling brain activity, while the HBP seeks to
create a working computational model of the entire brain. As so elo-
quently put by Reardon (2014), ‘just as the HBP needs actual brain
data to design its model, the BRAIN Initiative needs a system for
integrating its massive amounts of biological data so that it can gen-
erate something meaningful’. Hence, instead of having another
‘space race’ on our hands, the emphasis inside the scientific commu-
nity should be on the possibilities of international collaboration.
However, on the political level, competition seems to be a pre-
vailing discourse inside the brain projects’ rhetoric. Not only do dis-
tinctions in national objectives cause variations in Grand Challenge
policies, but also diverse industrial and political environments influ-
ence the design and operation of both presented brain initiatives.10
In an era of brain science where the potential for scientific advance
is within reach and the societal need is great, how these projects will
fare and their ultimate outcomes will only be revealed with the pas-
sage of time (and rigorous evaluation). Kalil (2012) writes that ‘sup-
port for curiosity-driven research is critical, both because expanding
the frontiers of human knowledge is an end in itself, and because it
leads to benefits that we could never have predicted’. Both projects
are pouring large amounts of money into neuroscience and the related
fields, encompassing and activating numerous scientists and organiza-
tions; hence, we are bound to achieve various beneficial spin-outs. But
more than the dollar amount of funding, it is clear that the organiza-
tion and implementation of these Grand Challenge projects will play a
significant role in determining their ultimate outcomes.
Notes
1. Around 2000 and during the first decade of the twenty-
first century, a number of other documents appeared
defining or listing so-called Grand Challenges in various
fields; some could be seen as academic Grand Challenge
papers, others as appeals for allocation of R&D en-
deavors and the necessary funding. For example, in 1998
Sears publishes ‘Grand Challenges in Computational
Biology’ (in Salsberg, Seals and Kasif (eds) Computational
Methods in Molecular Biology, Elsevier, 1998); global
health scientists, under the leadership of Dr Abdallah
Daar, identified a set of Grand Challenges in Chronic
Noncommunicable Diseases (published in Nature magazine
in November 2007); US National Academy of Engineering
published Grand Challenges in Engineering in 2008, a
work also mentioning reverse engineering of the brain; or
the 2010 commitment to use science, technology, and in-
novation to address Grand Challenges by Dr Rajiv Shah
(the Administrator of US Agency for International
Development), etc. Omenn (2006) in his Science article
also gives a short overview of some Grand Challenge en-
deavors, for example, inside scientific and engineering
fields; he, however, does not focus on brain research
Grand Challenges.
2. We can emphasize two milestones. First, the naming of
one of the pillars of the EU’s main research and innov-
ation program Horizon 2020 as Societal Challenges. These
are closely related to Grand Challenges and have emerged
from discussions on the need for Europe’s research system
to respond to a series of Grand Challenges (see e.g. the
opinion by the then chair of the EC’s ERA Rationales
Expert Group, Georghiou (2008)). Second, the US
Presidents 21st Century Grand Challenges—Obama’s
Grand Challenge manifesto declares a series of Grand
Challenges.
3. DALY is a unit for measuring the amount of health lost
because of a disease or injury and is calculated as the
present value of disability-free life that is lost as a result
of the premature deaths or disability.
4. Markram has been an important figure even before the
beginning of the Blue Brain Project. In 2002, he founded
the Brain Mind Institute at the EPFL, the leading partner
of the HBP. The Blue Brain Project started with EPFL
and IBM signing an agreement in 2005 (note that IBM
never funded the project per se). In January 2007, it was
presented to the Davos forum and in 2013—the same
time HBP became a flagship initiative—the Blue Brain
Project becomes a National Research Infrastructure.
Interestingly, Blue Brain was sometimes heavily criticized
as scientists have even claimed that the Blue Brain ‘as a
scientific folly and a waste of public money . . . would
sap support from other areas of brain research’ (Enserink
and Kupferschmidt 2014).





6. Indeed just prior to ending the first Ramp-Up phase at the
end of April and entering the Operational phase the HBP
has offered initial versions of six ICT Platforms to users
outside the Project, consisting of prototype hardware, soft-
ware tools, databases, and programming interfaces (some
freely accessible, others available after a successful peer-
reviewed application). Some scientist warn that we are yet
to see, how these will resonate with brain researchers
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outside the project (Schiermeier and Abbott 2016).
7. As already written, the selection of the flagships has been
a multiyear and a multistep procedure. Of twenty-one eli-
gible proposals received following the initial call, six
pilots (‘preparatory actions’) were selected in January
2011, after which six contenders received around e1.5
million in funding over a year to refine their proposals.
At the end of October 2012, six finalists submitted their
complete research proposals, including a roadmap and im-
plementation plan, together with a detailed and thorough
justification for the proposed investment. Only two were
selected in the end.




9. The commitment of the Simons foundation in 2014 repre-
sents—beside the Allen Foundation support—the biggest
(nongovernmental) contribution to date and the involvement
of one of the biggest US foundations, as well as a some-
what older foundation incorporated during the Decade of
the Brain. Interestingly, Kavli’s promised $4 million per
year for the next 10 years, is basically the amount of their
distributed grants in its entirety and will in total drain the
foundation of more than a fourth of its total assets (com-
paring this with the data found in Foundation Directory
Online—signaling also a strong financial commitment to
this project. Nonetheless, it remains in financial sense
among the smaller private contributors.
10. Same could be said for other policy initiatives (see e.g.
Anadon’s 2012 analyses of energy R&D in three countries).
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